课题基金 / 基金详情

Venezuelan Equine Encephalitis Immunology and Vaccine Design

Venezuelan Equine Encephalitis Immunology and Vaccine Design
委内瑞拉马脑炎免疫学和疫苗设计
批准号:
8116627
负责人:
Micah T. McClain
金额:
$12.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-10 至 2014-07-31

项目摘要

项目成果

Micah T. McClain的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):本提案描述了一项为期5年的项目,旨在支持PI发展为病毒免疫学和疫苗设计方面的独立研究者。在此计划期间,PI将建立在人类免疫学的坚实基础上,作为过渡到转化病毒学和疫苗学职业生涯的一种手段。为了实现这一目标,该提案涉及从委内瑞拉马脑炎(VEE)病毒重要抗原区域的发现和描述到预防VEE感染的新疫苗的设计、构建和临床前测试的完整进展。为了解决VEE缺乏任何市售治疗或疫苗的问题,本提案的研究目的是:1)表征委内瑞拉马脑炎病毒体液免疫应答对两个关键抗原靶标的良好特异性:VEE结构蛋白E1和E2,2)为了鉴定E1和E2的哪些共同抗原靶点引发保护性免疫,并建立个体抗体特异性的相对贡献,3)表征通过疫苗接种暴露于活的减毒TC-83病毒株的个体中对VEE的细胞免疫应答,和4)在小动物模型中测试目的1-3中鉴定的B和T细胞靶标作为候选疫苗抗原的能力。除了新方法和技术的实践培训外,候选人还将参加旨在促进科学独立性发展的综合课程。该课程将包括关于病毒学和疫苗的研讨会和专题讨论会,在国家会议上介绍研究成果,通过经典课程和国家讲习班进行教学培训,并与精心挑选的病毒学和疫苗设计和实施的基础和临床研究方面的专家咨询委员会进行密切的个人互动。该提案旨在充分利用两所紧密结盟和位置优越的大学-杜克大学和北卡罗来纳大学教堂山分校-的众多优势,以最大限度地提高该计划的曝光率和培训方面。这种环境培养了合作精神,并为开展独立的科学事业提供了理想的环境。相关性(参见说明):委内瑞拉马脑炎是北美和南美部分地区的主要人类病原体,可导致严重头痛,肌痛,虚脱,脑炎,甚至死亡。这是一个疾病预防控制中心指定的B类选择代理,确定其潜在的用途作为一个代理的生物恐怖主义,事实上VEE是少数代理人,实际上已经武器化的美国和苏联在过去。目前没有已知的治疗剂或市售疫苗用于预防VEE感染。
英文摘要
DESCRIPTION (provided by applicant): This proposal describes a 5 year program designed to support the development of the PI into an independent investigator in viral immunology and vaccine design. During this program the PI will build upon a strong foundation in human immunology as a means to transition into a career in translational virology and vaccinology. In order to attain this goal, this proposal involves the complete progression from discovery and description of important antigenic regions of the Venezuelan Equine Encephalitis (VEE) virus through the design, construction, and preclinical testing of a new vaccine for prevention of VEE infection. In order to address the lack of any commercially available treatment or vaccine for VEE, the research Aims of this proposal are: 1) To characterize the fine specificity of the Venezuelan Equine Encephalitis virus humoral immune response to two key antigenic targets: VEE structural proteins E1 and E2, 2) To identify which common antigenic targets of E1 and E2 elicit protective immunity and establish the relative contribution of individual antibody specificities, 3) To characterize the cellular immune responses to VEE in individuals exposed to the live, attenuated TC-83 strain of virus through vaccination, and 4) Test the ability of the B and T cell targets identified in Aims 1-3 as candidate vaccine antigens in a small animal model. In addition to practical training in new methodologies and techniques, the candidate will participate in an integrated curriculum designed to foster the development of scientific independence. This curriculum will involve seminars and symposia on virology and vaccines, presentation of research at national meetings, didactic training through classical coursework as well as national workshops, and close personal interactions with a carefully selected Advisory Committee of experts on the basic and clinical research aspects of virology and vaccine design and implementation. This proposal is designed to take full advantage of the myriad strengths of two closely allied and situated Universities - Duke and UNC-Chapel Hill - in order to maximize the exposure and training aspects of the program. This environment fosters a collaborative spirit and provides an ideal setting for launching an independent science career. RELEVANCE (See instructions): Venezuelan Equine Encephalitis is a major human pathogen throughout parts of North and South America which can cause severe headaches, myalgias, prostration, encephalitis, and even death. It is a CDC- designated Category B Select Agent, identifying its potential use as an agent of bioterrorism, and in fact VEE is one of the few agents that has actually been weaponized by both the US and USSR in the past. There are currently no known therapeutic agents or commercially available vaccines for the prevention of VEE infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host-derived biomarker signatures for the diagnosis of acute rickettsial diseases
  • 批准号:
    10291785
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    Micah T. McClain
  • 依托单位:
Host-derived biomarker signatures for the diagnosis of acute rickettsial diseases
  • 批准号:
    9860904
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    Micah T. McClain
  • 依托单位:
Host-derived biomarker signatures for the diagnosis of acute rickettsial diseases
  • 批准号:
    10427237
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    Micah T. McClain
  • 依托单位:
Host-derived biomarker signatures to differentiate acute viral, bacterial, and fungal infection
  • 批准号:
    9373089
  • 项目类别:
  • 资助金额:
    $19.88万
  • 财政年份:
    2017
  • 负责人:
    Micah T. McClain
  • 依托单位:
海外基金